FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced pre-clinical data the Company will present at 1:15 CST today at the 2010 Orthopedic Research Society (ORS) meeting in New Orleans. The Company’s sports medicine team will present results of two pre-clinical studies demonstrating that rhPDGF-BB, in combination with tissue specific matrix materials, promotes healing in tendon-tendon and tendon-bone injuries. In addition, in vitro data demonstrating rhPDGF-BB’s ability to stimulate tenocytes (tendon cells) will also be presented.
